The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
0740 GMT – Sanofi’s decision to separate its consumer-healthcare business is likely to be overshadowed by its plans to step up investment, which should result in big cuts to consensus expectations for next year and 2025, Barclays Capital analysts say in a research note. The French pharmaceutical company expects business EPS to be roughly flat in 2024 compared with this year due to increased research-and-development investment and a strong rebound in 2025. This new guidance will be the primary focus for investors, Barclays says. “Our early take on these strategic actions is that the separation of [consumer healthcare] is the right thing to do strategically, but we are expecting a negative reaction in shares today on the 2024 and 2025 numbers cuts,” Barclays says. Shares fall 16%. ([email protected])
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : The Wall Street Journal – https://www.wsj.com/articles/health-care-roundup-market-talk-b1dee13e
